Purchase Order 75F40123P00021
Award Date
1/10/23
Potential Completion Date
12/19/23
Potential Value
$14K
Federal Agency
Food and Drug Administration
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lakewood, CO 80225, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Illumina, Inc. was awarded a $191,035 firm fixed price purchase order by the Department of Health and Human Services' Food and Drug Administration for a preventative maintenance and support plan for existing instruments. The contract has no set-aside designation and runs through February 6, 2025. As the sole awardee, Illumina will provide preventative maintenance and support services to the FDA to keep instrumentation operational and ensure continued performance. The award is for an existing...
This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for an annual maintenance agreement covering seven Illumina sequencing instruments. The contract has a base year and four option years, with a total potential value of $817,521.04. Illumina, a manufacturer of sequencing and genomic analysis technologies, has a history of providing sequencing systems, reagents, and maintenance services to federal agencies for various research and...
This firm fixed-price delivery order, valued at $201,939.00, was awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The award does not have a set-aside designation. Illumina is a manufacturer of genetic sequencing systems and has a history of supporting genomic research and diagnostics across multiple federal agencies. This award indicates Illumina is providing maintenance services to help ensure the...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $180,080.00, is for a preventive maintenance agreement on an Illumina Next Generation Sequencer. The contract has a completion date of November 12, 2024 and was awarded on October 24, 2019. Illumina has a history of providing sequencing systems,...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for $170,153.16 to provide annual on-site preventative maintenance service and unlimited repairs as needed on two Illumina MiSeq whole genome sequencers for a base year plus four option years. The contract has no set-aside designation. Based on Illumina's history as a prime contractor and subcontractor for sequencing systems and services across various federal agencies, this award aligns...
This is a $77,592.11 firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The order is for the addition of items from Requisition #1168475, with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies, including the National Institutes of Health (NIH),...
The U.S. Food and Drug Administration (FDA) awarded Illumina, Inc. a firm fixed-price purchase order worth $425,145.40 for a 12-month preventative maintenance service agreement with four 12-month option periods. This award is in support of five MiSeq sequencing instruments for the FDA's Center for Food Safety and Applied Nutrition (CFSAN). As the original equipment manufacturer (OEM) and sole authorized provider of maintenance for the MiSeq instruments, Illumina was awarded this sole-source...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $212,705.80 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The purchase order is for Illumina MiSeq service contracts to support the FDA's microbial genomics program, which requires the maintenance of 10 MiSeq sequencing instruments to perform bacterial foodborne pathogen genome sequencing, targeted gene sequencing, and...
Illumina, Inc. has been awarded a $102,963.12 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration for Illumina reagent chemistry kits. The delivery order was issued under an indefinite delivery contract with no set-aside provisions and calls for Illumina to provide its proprietary reagent kits to support genomic sequencing and analysis at the agency through August 2024. As the sole manufacturer of the sequencing instruments in use,...
The Department of Health and Human Services Food and Drug Administration awarded a $67,963.80 firm fixed price purchase order to Illumina, Inc. for corrective, remedial, repair, and preventive maintenance services for Illumina's MiSeq sequencing systems. The contract has a period of performance through February 28, 2025 and was awarded on December 12, 2019. No set-aside designation was used for this award to support the FDA's medical device evaluation programs through ongoing maintenance and...